| Trial ID: | L1749 |
| Source ID: | NCT00004466
|
| Associated Drug: |
Atorvastatin
|
| Title: |
Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
|
| Acronym: |
|
| Status: |
TERMINATED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Nephrotic Syndrome|Hyperlipidemia
|
| Interventions: |
DRUG: Atorvastatin|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change in plasma lipid levels, One year |
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Collaborators: Southwest Pediatric Nephrology Study Group
|
| Gender: |
ALL
|
| Age: |
CHILD
|
| Phases: |
PHASE2
|
| Enrollment: |
5
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
1998-10
|
| Completion Date: |
1999-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-09-15
|
| Locations: |
Medical City Dallas Hospital, Dallas, Texas, 75230, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00004466
|
